These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6492695)

  • 1. Importance of early postprandial insulin delivery in insulin-dependent diabetics.
    Kerner W; Moll H; Navascués I; Pfeiffer EF
    Klin Wochenschr; 1984 Aug; 62(15):738-44. PubMed ID: 6492695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
    Underland LJ; Ilkowitz JT; Katikaneni R; Dowd A; Heptulla RA
    J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of individual insulin infusion profiles for open loop infusion systems.
    Strack T; Krause U; Schulz G; Beyer J; Beutelspacher F; Nagel J
    Horm Metab Res; 1984 Apr; 16(4):163-7. PubMed ID: 6547110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic response of normal man and insulin-infused diabetics to postprandial exercise.
    Nelson JD; Poussier P; Marliss EB; Albisser AM; Zinman B
    Am J Physiol; 1982 May; 242(5):E309-16. PubMed ID: 7044140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response.
    Shichiri M; Kawamori R; Hakui N; Yamasaki Y; Abe H
    Diabetes; 1984 Dec; 33(12):1200-2. PubMed ID: 6389235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of macronutrient content of meals on postprandial glucose control in the context of closed-loop insulin delivery: A randomized cross-over study.
    Gingras V; Bonato L; Messier V; Roy-Fleming A; Smaoui MR; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2018 Nov; 20(11):2695-2699. PubMed ID: 29931719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
    Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
    Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
    Cobry E; McFann K; Messer L; Gage V; VanderWel B; Horton L; Chase HP
    Diabetes Technol Ther; 2010 Mar; 12(3):173-7. PubMed ID: 20151766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
    Ilkowitz JT; Katikaneni R; Cantwell M; Ramchandani N; Heptulla RA
    J Diabetes Sci Technol; 2016 Sep; 10(5):1108-14. PubMed ID: 27184690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
    Levetan C; Want LL; Weyer C; Strobel SA; Crean J; Wang Y; Maggs DG; Kolterman OG; Chandran M; Mudaliar SR; Henry RR
    Diabetes Care; 2003 Jan; 26(1):1-8. PubMed ID: 12502651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal pattern of insulin requirements in insulin-dependent diabetics.
    Mathiesen ER; Rubin P; Sandahl Christiansen J; Aaby Svendsen P; Lauritzen T; Deckert T
    Scand J Clin Lab Invest; 1982 Feb; 42(1):63-8. PubMed ID: 6753093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control with closed-loop intraperitoneal insulin in type I diabetes.
    LeBlanc H; Chauvet D; Lombrail P; Robert JJ
    Diabetes Care; 1986; 9(2):124-8. PubMed ID: 3516606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.